Foka Elite

Home/Blog/Weight loss/Constipation

The fibre advice is written for the wrong problem

By Oleksandr Foka — sports nutritionist. Works in world title camps and on the WTA tour, and runs a small number of private programmes alongside that.

Every article on this subject ends the same way: drink more water, eat more fibre. That advice is correct for one of the three kinds of constipation, and the one the drug actually causes is not it.

Getting the type wrong does not just waste your time. Loading bulk fibre into a gut that has been slowed down deliberately can make the bloating worse, which is why so many people report doing everything they were told and feeling more uncomfortable for it.

What the drug is doing down there

Slowing the gut is not a side effect. It is part of how the thing works.

Activating GLP-1 receptors in the digestive tract inhibits gastric emptying and suppresses the migrating motor complex, which is the housekeeping wave that sweeps the small intestine between meals. Food moves through more slowly. That is the mechanism that makes you feel full, and it is inseparable from the mechanism that makes you constipated.

The consequence downstream is simple physics. The longer material sits in the colon, the more water gets absorbed out of it, and the drier and harder it arrives. Reduced gastric and intestinal secretion pulls in the same direction, lowering the water content of the stool before it ever reaches the colon.

There is a central component too. These drugs reach the brainstem, and receptor activation there alters vagal outflow and the gut-brain reflexes that govern motility. Which is part of why the bloating can feel disproportionate to what is actually in there.

The numbers

Measured by scintigraphy and breath testing, GLP-1 therapy prolongs the half-time of solid gastric emptying by 30 to 40 percent compared with placebo. Pooled meta-analysis puts the absolute delay at around 36 minutes, though the confidence intervals differ between analyses and the honest version of that number is wide.

A case series using a wireless motility capsule found delayed gastric emptying in 80 percent of patients and delayed whole-gut transit in 44 percent, with the longest transit times belonging to the people on semaglutide 1 mg. Ten patients, retrospective, so hold it lightly.

So the delay is real, measurable, and rather larger than most patients are led to expect.

The three types, and why the distinction matters

Clinicians working with this population are told to separate three patterns before advising anything.

Slow-transit. The one most characteristically associated with these drugs. Bowel movements become infrequent. The machinery has been turned down.

Normal-transit. Transit is fine; hydration or fibre intake is not. This is the ordinary constipation of eating almost nothing, and it is common on a suppressed appetite for reasons that have nothing to do with receptors.

IBS-type. Alternating patterns, bloating, discomfort out of proportion to frequency.

Now the practical point. The standard advice, more fibre and more water, is aimed squarely at the second type. Applied to the first, adding bulking fibre to a colon that is already moving slowly gives the slow system more to move, and the usual result is more distension rather than less.

This is why people describe eating bran and feeling worse. They did not fail to follow the advice. They followed advice written for a different problem.

The thing nobody tells you about timing

The most useful fact in this whole article is almost never mentioned.

The gastric slowing is subject to rapid tachyphylaxis. In plain terms, the gut adapts and the effect fades with continued exposure. It is at its strongest when you start, and again after every dose increase.

That has two consequences worth knowing.

The first is reassurance with a date attached. If your worst week was the week after a titration, that is the expected pattern rather than a sign that something is going wrong.

The second is counterintuitive. It is part of why the short-acting agents like exenatide and lixisenatide slow the stomach more than the long-acting weekly ones do, despite being older and less potent drugs. Constant exposure produces adaptation. Intermittent exposure does not.

I will not push that further into a ranking of which drug constipates least, because the meta-analyses disagree with each other on that and anyone telling you otherwise is picking the one that suits them.

What sits in my half of this

Laxatives are a medical decision. Osmotic agents, the ones that draw water into the bowel rather than stimulating it, are what clinicians reach for in this setting, and whether you use one is a conversation with your prescriber. I am not going to make that call from a webpage.

The food side, which is mine:

One thing to raise with a doctor, unprompted

If you have a procedure under sedation coming up, an endoscopy, a colonoscopy, surgery of any kind, tell the team you are on one of these drugs and do it early rather than on the morning.

The reason is the same delayed emptying discussed above. Retained stomach contents are found more often in patients on GLP-1 drugs, standard fasting intervals were not designed with them in mind, and with weekly formulations skipping a single dose does not reliably normalise transit. Guidance is still being argued over. Your anaesthetist would rather know.

That is not nutrition advice and it is outside my lane, but it is the one thing in this article that could matter more than the rest combined.

The short version

The slowing is not a malfunction, it is the drug working, and it is worst at the start and after each increase before the gut adapts. The fibre advice everyone gives you was written for a different kind of constipation than the one you have. Water matters more than bulk, timing of the dose increase explains most of the bad weeks, and the type of fibre matters more than the amount.

Working together

The private programme builds meals around a slowed gut and a suppressed appetite rather than issuing generic fibre targets, with fluid and micronutrients tracked rather than assumed. What it covers.

Oleksandr Foka — sports nutritionist.